Global HealthPharmaceutical Regulations in Japan

Capacity Building

In order to improve access to medicines, it is important to not only provide practical guidance on local capacity building but also education and training.

In developing countries, access to medicines is obstructed by various factors, such as an inadequate public health insurance system and medical infrastructure, shortfalls in the human resources needed for the manufacture and quality management of medicines, the spread of counterfeit medicines and poverty.
JPMA and its members believe that capacity building in developing countries - specifically know-how transfer and educational training - is an important part of improving access to medicines.

1) Know-how transfer

JPMA and its member companies are providing technical assistance in cooperation with stakeholders on the manufacture and quality management of pharmaceuticals in order to improve access to medicine in developing countries.

2) Training

In developing countries, patients are not always able to receive appropriate medical care due to a lack of medical resources and a shortage of skilled healthcare professionals. JPMA and its member companies, in cooperation with developing country governments, are working to improve the ability of healthcare professionals involved in disease prevention, diagnosis, and treatment to improve healthcare in these countries.

3) Initiatives to improve access to healthcare

In developing countries, there are still many areas that suffer from insufficient medical access due to lack of social and medical infrastructure. Furthermore, in addition to a lack of healthcare knowledge, there continues to be areas that lack opportunities for people to learn about hygiene and disease prevention as well. JPMA and its member companies contribute to improve medical and health care via improving hygiene and awareness to medical care and access to healthcare for peoples living in local areas.

Initiatives by member companies

Financial assistance to cultivate and develop health workers
Takeda Pharmaceutical Company Limited is implementing a donation program, the "Takeda Initiative", to cultivate and develop health workers in Africa through the Global Fund to Fight AIDS, Tuberculosis and Malaria. A total of 1 billion yen (US$12 million) is planned to be donated over 10 years from 2010 to 2019.
Acceptance of fellows and provision of training in developing countries
Astellas Pharma Inc. and Eisai Co., Ltd. have each accepted Fellows (trainees) from developing countries at their overseas offices through the WHO-TDR (WHO's Special Programme for Research and Training in Tropical Diseases) Clinical Research Fellowships. Clinical researchers were provided with specialist training and hands-on experience, in order to build capacity in clinical development in the developing world.
Astellas and Eisai accept fellows via WHO-TDR program (the neglected tropical disease medical special research and development program), and provide the opportunities of clinical research capacity building.
Astellas accepted fellows from Botswana and Ethiopia in 2011 and 2013, respectively, at the US clinical research development. The program provided trainings regarding the international clinical development standard for the capacity building in developing countries.
Eisai accepted fellows in Eisai Inc (NJ, USA), one from Nigeria in 2010, and the other from Columbia in 2011, providing trainings for management skills of clinical development and clinical studies. After going back to their countries, they have been playing leading roles in the diagnosis, and treatments of communcable diseases, also the development of pharmaceuticals in their own countries.
Improvement of diagnostic technology for dementia/provision of education on illnesses
In India, Eisai is currently lending its support to the opening of memory clinics across the country to facilitate the early detection and treatment of dementia, and is engaged in educational programs for doctors as well as education on illnesses.
Technical cooperation for manufacturing of MR vaccine (mixed vaccine for measles and rubella)
Kitasato Daiichi Sankyo Vaccine, a subsidiary of Daiichi Sankyo, currently provides technical support for the domestic manufacture of the first mixed vaccine for measles and rubella in Vietnam.
Mobile medical services to improve access to healthcare
Daiichi Sankyo is implementing a mobile medical service in doctorless villages in India, Tanzania and Cameroon.
Since 2011, the company has cooperated with NGOs, local governments and communities to provide immunizations to infants and small children, medical examinations for pregnant and parturient women, and other medical care services using mobile medical services, and has cultivated public health clinics for providing support for local activities.
Provision of education on diseases/patient education support programs using smartphones
Astellas provides illness awareness and patient education support programs regarding "overactive bladders" for smartphone users that can be accessed around the world. Understanding towards patients who suffer from overactive bladders continues to be insufficient.
The intention of the aforementioned program is to have patients themselves deepen their understanding and work towards controlling their illness of their own accord through understanding regarding their illness and condition, physical activity instruction for improving symptoms, daily recordkeeping of symptoms, and so forth
Malaria Awareness Building
Sumitomo Dainippon Pharma supports Malaria No More Japan (MNMJ) activities via donation, and also assists holding the event for Malaria enlightenment.
Financial assistance to examine tuberculosis
Sumitomo Dainippon Pharma supports Future Code (NGO) which operates to improve medical examination for tuberculosis and capacity building for healthcare workers.
Support Health Improvement for Mothers and Children
Daiichi Sankyo launched an initiative through an international NGO, Plan Japan, in the rural areas of Yunnan Province, which has one of the highest stunting rates in China.
Daiichi Sankyo provides support to help improve the health of mothers and children by developing medical professionals through additional training and promoting health education in the community.

Page Top

  • Office of Pharmaceutical Industry Research(OPIR)
  • Global Health
  • Stop AMR
  • APAC